大摩:中國化工需求復甦或更早 升上石化(0338.HK)評級至“增持”
摩根士丹利發表報告表示,中國化工需求的復甦或比全球其他地區更早更強,上調行業評級至有吸引力,並將上石化(0338.HK)H股評級升至“增持”,目標價上調16%至2.27港元。
報告指,更便宜的油價意味美國以乙烷為基礎的新化工產能,在成本上的競爭力不如中國及亞洲的石腦油裂解公司。
該行指,上石化被深度低估,故將其H股評級升至“增持”,目標價上調16%至2.27港元;而A股目標價亦上調16%至2.08元(人民幣,下同),維持“減持”評級。
該行亦上調多家A股上市公司目標價,當中榮盛石化(002493.SZ)目標價升108%至25.51元,公司積極擴張產能;而萬華化學(600309.SH)目標價亦上調55%至81.8元。金髮科技(600143.SH)及三棵樹(603737.SH)目標價分別升36%及148%,至18.21元及183.34元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.